Versaterm acquires American mental health platform for first responders
This is the public safety tech firm’s second acquisition within the past month.
Healthtech
Biointelligence raises $5 million for biomanufacturing efficiency platform
The company intends to use the funds to accelerate growth in the United States and Europe.
Pendium Health wins $10,000 at OCI’s DiscoveryX Conference
DiscoveryX returned to Toronto’s Enercare Centre this month after a four-year hiatus.
H|T: The Healthtech Times – AbCellera plays the long game despite losses
Plus: The BC telemedicine company that was allegedly a “pump and dump.”
Forcen closes $8.35 million in funding to develop its touch-tech for robots
The round was co-led by Brightspark Ventures and BDC Capital’s Deep Tech Venture Fund.
H|T: The Healthtech Times – Bayer taps Google to bring AI to radiology
Plus: The role of telehealth providers in antibiotic overuse.
Well Health acquires 10 primary care medical clinics from Shoppers Drug Mart
Well says it will integrate digital workflows, patient engagement tech, and AI tools into the clinics once acquired.
H|T: The Healthtech Times – Teladoc CEO axed after 15 years at the helm
Plus: An AI company uses your nudes to detect STIs.
Appili Therapeutics to be acquired by Virginia-based life sciences company Aditxt
Deal is contingent upon Aditxt raising at least $20 million USD.
H|T: The Healthtech Times – Ontario budget allocates funding to healthtech procurement
Plus: Neuralink is now accepting Canadian patients.
H|T: The Healthtech Times – AstraZeneca pays $2B for Hamilton biopharma firm
Plus: Neuralink’s first human subject shows off abilities on livestream.
Ontario Budget 2024 tops up existing funds and innovation centres, allocates funding to healthtech procurement
Province hints that the OSC is developing new rules to support angel investors.
Dialogue acquires IP, other assets of fellow digital health platform Koble
Deal is hoped to strengthen Dialogue’s support for women’s healthcare.
H|T: The Healthtech Times – Toronto biotech secures $2.2M to treat immune diseases
Plus: Healthcare startup Tempus preps for IPO.
Fusion Pharmaceuticals to be acquired by AstraZeneca for more than $2 billion USD
AstraZeneca says the deal marks “a major step forward” in its goal to transform cancer treatment.